Carregant...

Immune Globulin Subcutaneous (Human) 20%: In Primary Immunodeficiency Disorders

Immune globulin subcutaneous 20% is a new high-concentration (200 g/L) solution of highly purified human IgG (≥98%) indicated in the EU and the US for antibody replacement therapy in patients with primary immunodeficiency with antibody deficiency, and in the EU for replacement therapy in humoral imm...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: McCormack, Paul L.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3582812/
https://ncbi.nlm.nih.gov/pubmed/22621695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11209490-000000000-00000
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!